
Am J Psychiatry 1978; 135:1081-1084
Copyright © 1978 by American Psychiatric Association
Phencyclidine-induced psychosis
RM Allen and SJ Young
During a 13-month period, 9 patients with phencyclidine-induced psychosis
were admitted to Darnall Army Hospital. They exhibited hostility agitation,
and tangentiality and had delusions of influence and religious grandiosity.
Six subjects reported auditory hallucinations, and 4 were disoriented in at
least 1 sphere. Despite treatment with antipsychotic medication, the
psychotic episodes often persisted for more than 30 days. Our clinical
finding of prolonged psychotic reactions, together with previous reports of
the effects of phencyclidine, suggests that phenycyclidine provides an
intriguing drug model for schizophrenia.
This article has been cited by other articles:

|
 |

|
 |
 
A. Fornito, M. Yucel, B. Dean, S. J. Wood, and C. Pantelis
Anatomical Abnormalities of the Anterior Cingulate Cortex in Schizophrenia: Bridging the Gap Between Neuroimaging and Neuropathology
Schizophr Bull,
April 23, 2008;
(2008)
sbn025v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. H. Large
Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?
J Psychopharmacol,
May 1, 2007;
21(3):
283 - 301.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Gu, Q. Jiang, and Z. Yan
RGS4 Modulates Serotonin Signaling in Prefrontal Cortex and Links to Serotonin Dysfunction in a Rat Model of Schizophrenia
Mol. Pharmacol.,
April 1, 2007;
71(4):
1030 - 1039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. NABESHIMA, A. MOURI, R. MURAI, and Y. NODA
Animal Model of Schizophrenia: Dysfunction of NMDA Receptor-Signaling in Mice following Withdrawal from Repeated Administration of Phencyclidine
Ann. N.Y. Acad. Sci.,
November 1, 2006;
1086(1):
160 - 168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Paterson, Y. Ohashi, G. P. Reynolds, J. A. Pratt, and B. J. Morris
Selective increases in the cytokine, TNF{alpha}, in the prefrontal cortex of PCP-treated rats and human schizophrenic subjects: influence of antipsychotic drugs
J Psychopharmacol,
September 1, 2006;
20(5):
636 - 642.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Narendran, W. G. Frankle, R. Keefe, R. Gil, D. Martinez, M. Slifstein, L. S. Kegeles, P. S. Talbot, Y. Huang, D.-R. Hwang, et al.
Altered Prefrontal Dopaminergic Function in Chronic Recreational Ketamine Users
Am J Psychiatry,
December 1, 2005;
162(12):
2352 - 2359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Enomoto, Y. Noda, A. Mouri, E.-J. Shin, D. Wang, R. Murai, K. Hotta, H. Furukawa, A. Nitta, H.-C. Kim, et al.
Long-Lasting Impairment of Associative Learning Is Correlated with a Dysfunction of N-Methyl-D-aspartate-Extracellular Signaling-Regulated Kinase Signaling in Mice after Withdrawal from Repeated Administration of Phencyclidine
Mol. Pharmacol.,
December 1, 2005;
68(6):
1765 - 1774.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Svenningsson, G. G. Nomikos, and P. Greengard
Response to Comment on "Diverse Psychotomimetics Act Through a Common Signaling Pathway"
Science,
July 9, 2004;
305(5681):
180d - 180d.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. TOYOOKA, M. USUI, K. WASHIYAMA, T. KUMANISHI, and Y. TAKAHASHI
Gene Expression Profiles in the Brain from Phencyclidine-Treated Mouse by Using DNA Microarray
Ann. N.Y. Acad. Sci.,
June 1, 2002;
965(1):
10 - 20.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. TOMITA, M. MURATA, H. WATANABE, T. ICHIKAWA, K. WASHIYAMA, T. KUMANISHI, and Y. TAKAHASHI
The Effects of DCG-IV and L-CCG-1 upon Phencyclidine (PCP)-induced Locomotion and Behavioral Changes in Mice
Ann. N.Y. Acad. Sci.,
September 1, 2000;
914(1):
284 - 291.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. H. McGlashan and R. E. Hoffman
Schizophrenia as a Disorder of Developmentally Reduced Synaptic Connectivity
Arch Gen Psychiatry,
July 1, 2000;
57(7):
637 - 648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. P. Bakshi and M. A. Geyer
Phencyclidine-Induced Deficits in Prepulse Inhibition of Startle are Blocked by Prazosin, an Alpha-1 Noradrenergic Antagonist
J. Pharmacol. Exp. Ther.,
November 1, 1997;
283(2):
666 - 674.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. T. Thompson and J. F. Disterhoft
N-Methyl-D-Aspartate Receptors in Associative Eyeblink Conditioning: Both MK-801 and Phencyclidine Produce Task- and Dose-Dependent Impairments
J. Pharmacol. Exp. Ther.,
May 1, 1997;
281(2):
928 - 940.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. H. Silverstone and D. G. Grahame-Smith
Smithkline Beecham Prize for Young Psychopharmacologists: A review of the relationship between calcium channels and psychiatric disorders
J Psychopharmacol,
January 1, 1992;
6(4):
462 - 482.
[Abstract]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 1978
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|